Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 4 1Phase 3 1Phase 2/3 1Phase 2 1

Status

Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 5INDUSTRY 3

Study Type

Interventional 3

Sponsor

Conditions

Breast Neoplasms 170Neoplasms 129Prostatic Neoplasms 92Lung Neoplasms 82Colorectal Neoplasms 80Pancreatic Neoplasms 38Leiomyoma 37Carcinoma, Hepatocellular 36Lymphoma, Follicular 35Carcinoma, Non-Small-Cell Lung 31Neoplasm Metastasis 27Skin Neoplasms 26Liver Neoplasms 26Colonic Neoplasms 26Uterine Cervical Neoplasms 25Multiple Myeloma 23Glioblastoma 22Head and Neck Neoplasms 21Barrett Esophagus 21Polycystic Ovary Syndrome 19Brain Neoplasms 18Urinary Bladder Neoplasms 17Polyps 16Ovarian Neoplasms 15Esophageal Neoplasms 15Stomach Neoplasms 14Squamous Cell Carcinoma of Head and Neck 14Rectal Neoplasms 14Carcinoma, Squamous Cell 14Carcinoma, Basal Cell 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × INDUSTRY × Chalazion × Clear all
NCT07405138 2026-02-19

Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion

Lumenis Be Ltd.

Phase NA Not yet recruiting
40 enrolled

Chalazion

NCT07039461 2026-01-06

Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion

Lumenis Be Ltd.

Phase NA Terminated
4 enrolled

Chalazion

NCT00832130 2011-12-12

Treatment of Meibomian Gland Dysfunction and Evaporative Dry Eye

TearScience, Inc.

Phase NA Completed
139 enrolled 14 charts

Dry Eye Syndromes, Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡